There has been a lot of research regarding marijuana recently. Today the word comes down that a pair of Australian researchers will soon conduct the world’s first clinical trial to determine if medical cannabis can slow the growth of glioblastoma, an aggressive type of brain tumor. Each year in Australia about 1,000 people are diagnosed with glioblastoma. Survival in most cases is less than a year, with some patients passing away in as quickly as six months. Australia legalized certain medical cannabis products in 2017, also removing long-standing restrictions on scientific cannabis research.

Dr. Janet Schloss, a naturopath, and nutritionist with The Endeavour College of Natural Health, and neurosurgeon Charlie Teo are looking to determine whether high-potency cannabis oil can aid and assist standard cancer treatments. The hope is that cannabis can help reduce tumor size along with chemo and radiation therapies. They are also hoping that THC will help reduce tumor regrowth. Dr. Schloss and Prof. Teo are running their clinical trial at the Endeavour College of Natural Health, involving a randomized trial.

Each participant will get medical cannabis treatments alongside their standard cancer treatment with the goal of determining what extent medical cannabis can aid and assist. Certainly an interesting move and one we will be keeping an eye on. Give us your thoughts in the comments below and stay tuned for more cannabis news coming very soon.